Try our beta test site
69 studies found for:    "Rhabdoid tumor"
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
Condition: Malignant Rhabdoid Tumors (MRT), Neuroblastoma
Intervention: Drug: LEE011
2 Active, not recruiting
Has Results
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
Condition: Childhood Atypical Teratoid/Rhabdoid Tumor
Interventions: Procedure: autologous hematopoietic stem cell transplantation;   Radiation: 3-dimensional conformal radiation therapy;   Drug: methotrexate;   Drug: leucovorin calcium;   Drug: etoposide;   Drug: cyclophosphamide;   Drug: cisplatin;   Biological: filgrastim;   Drug: carboplatin;   Drug: thiotepa;   Drug: vincristine sulfate;   Other: laboratory biomarker analysis
3 Recruiting Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
Conditions: Malignant Rhabdoid Tumor;   Atypical Teratoid Rhabdoid Tumor
Interventions: Drug: alisertib;   Drug: methotrexate;   Drug: cisplatin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: topotecan;   Drug: vincristine;   Procedure: Surgical resection;   Radiation: Radiation therapy
4 Completed Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors
Condition: Kidney Cancer
Interventions: Genetic: DNA analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: gene mapping;   Genetic: microarray analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
5 Unknown  Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
6 Completed Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Conditions: Brain and Central Nervous System Tumors;   Kidney Cancer
Interventions: Genetic: DNA analysis;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
7 Withdrawn Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
Conditions: Brain and Central Nervous System Tumors;   Kidney Cancer
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: laboratory biomarker analysis
8 Recruiting Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
Conditions: Medulloblastoma, Childhood, Recurrent;   Atypical Teratoid/Rhabdoid Tumor;   Medulloblastoma Recurrent
Interventions: Biological: Modified Measles Virus;   Biological: Modified Measles Virus Lumbar Puncture
9 Active, not recruiting
Has Results
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: vincristine;   Procedure: autologous hematopoietic stem cell transplantation;   Radiation: radiation therapy
10 Completed Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: Oxaliplatin
11 Completed
Has Results
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
Condition: Central Nervous System Tumor, Pediatric
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: temozolomide;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Radiation: radiation therapy;   Drug: Dactinomycin
12 Recruiting A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Conditions: Rhabdoid Tumors;   INI1-negative Tumors;   Synovial Sarcoma;   Malignant Rhabdoid Tumor of Ovary
Intervention: Drug: Tazemetostat
13 Recruiting Study of Stored Tumor Samples in Young Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Intervention:
14 Withdrawn Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Congenital Mesoblastic Nephroma;   Rhabdoid Tumor of the Kidney;   Wilms Tumor and Other Childhood Kidney Tumors
Intervention: Other: laboratory biomarker analysis
15 Unknown  Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
Conditions: Glioblastoma;   Astrocytoma;   Pineoblastoma;   Rhabdoid Tumor;   Supratentorial Neoplasms
Intervention: Procedure: Stem Cell Transplant
16 Recruiting A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Conditions: Malignant Rhabdoid Tumors (MRT);   Rhabdoid Tumors of the Kidney (RTK);   Atypical Teratoid Rhabdoid Tumors (ATRT);   Selected Tumors With Rhabdoid Features;   Synovial Sarcoma;   INI1-negative Tumors;   Malignant Rhabdoid Tumor of Ovary;   Renal Medullary Carcinoma;   Epithelioid Sarcoma;   Any Solid Tumor With an EZH2 GOF Mutation
Intervention: Drug: Tazemetostat
17 Recruiting Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
Conditions: Recurrent Childhood Medulloblastoma;   Recurrent Childhood Ependymoma;   Childhood Atypical Teratoid/Rhabdoid Tumor;   Embryonal Tumor With Abundant Neuropil and True Rosettes;   Metastatic Malignant Neoplasm to the Leptomeninges
Interventions: Drug: Intra thecal methotrexate;   Drug: topotecan;   Drug: cyclophosphamide
18 Recruiting Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study
Conditions: Diffuse Large B-cell Lymphoma;   Follicular Lymphoma;   Malignant Rhabdoid Tumors (MRT);   Rhabdoid Tumors of the Kidney (RTK);   Atypical Teratoid Rhabdoid Tumors (ATRT);   Synovial Sarcoma;   Epitheliod Sarcoma;   Mesothelioma;   Advanced Solid Tumors
Intervention: Drug: Tazemetostat
19 Active, not recruiting Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Conditions: Ewing's Sarcoma;   Osteosarcoma;   Astrocytoma;   Atypical Teratoid/Rhabdoid Tumor;   Ependymoma;   Germ Cell Tumor;   Glioma;   Medulloblastoma;   Rhabdoid Tumor;   Retinoblastoma;   Clear Cell Sarcoma;   Renal Cell Carcinoma;   Wilms Tumor;   Hepatoblastoma;   Neuroblastoma;   Rhabdomyosarcoma
Intervention: Drug: sirolimus
20 Not yet recruiting Phase II Pediatric Study With Dabrafenib in HGG Patients
Conditions: Anaplastic Astrocytoma;   Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Anaplastic Ependymoma;   Choroid Plexus Carcinoma;   Anaplastic Ganglioglioma;   Pineal Parenchymal Tumor;   Pineoblastoma;   Medulloblastoma;   PNET;   Rhabdoid Tumor;   Perineurioma;   MPNST;   Malignant Meningloma;   Anaplastic Hemangiopericytoma
Intervention: Drug: dabrafenib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.